Norovirus is stable on surfaces for many hours and is not affected by the use of hand sanitizers or mild household cleaners
Roche with its 2024 acquisition of Carmot, and Pfizer, following its 2025 acquisition of Metsera, enter obesity and broaden their presence in cardiovascular/metabolic, while other large pharmaceutical companies prepare to follow later in the decade
3.3.2 Monomeric components of TCM The active components of certain traditional Chinese medicines can inhibit ferroptosis through multiple targets and pathways, thereby preventing and treating osteoporosis (Table 3)
According to a recent pulse survey from the International Foundation of Employee Benefit Plans: 76 percent of employers already cover GLP-1 drugs for diabetes 27 percent cover the drugs for weight loss 13 percent are considering adding coverage for weight loss 63 percent said the risk of chronic diseases and other costs associated with obesity were a top factor in their GLP-1 coverage decision For employers considering adding the coverage, there are some steps you can take to manage who is able to receive coverage and to help contain costs, according to information from Employers Health: For diabetes, best practices include first confirming there is a diabetes diagnosis and a prior attempt to use a different drug
J., & Chrousos, G
Clinically, this is why constipation and bloating are so common early in treatment or after dose increases
